About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 401623, 6 pages
http://dx.doi.org/10.1155/2013/401623
Clinical Study

Platelets and Inflammatory Markers in Patients with Gastric Cancer

1Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, J. Waszyngton 15a, 15-269 Bialystok, Poland
2Second Department of General and Gastroenterological Surgery, Medical University of Bialystok, M. Sklodowska-Curie 24a, 15-264 Bialystok, Poland
3Department of Haematological Diagnostics, Medical University of Bialystok, J. Waszyngton 15a, 15-269 Bialystok, Poland

Received 15 November 2012; Revised 5 February 2013; Accepted 17 February 2013

Academic Editor: Mario Clerici

Copyright © 2013 Joanna Matowicka-Karna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Brenner, D. Rothenbacher, and V. Arndt, “Epidemiology of stomach cancer,” Methods in Molecular Biology, vol. 472, pp. 467–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. H. H. Hartgrink, E. P. Jansen, N. C. van Grieken, and C. J. van de Velde, “Gastric cancer,” The Lancet, vol. 374, no. 9688, pp. 477–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Hussain and C. C. Harris, “Inflammation and cancer: an ancient link with novel potentials,” International Journal of Cancer, vol. 121, no. 11, pp. 2373–2380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. K. Kim, S. Y. Oh, H. C. Kwon et al., “Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer,” BMC Cancer, vol. 9, article 155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ikeda, H. Furukawa, H. Imamura et al., “Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor,” Gastric Cancer, vol. 5, no. 3, pp. 137–141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. G. R. Smith and S. Missailidis, “Cancer, inflammation and the AT1 and AT2 receptors,” Journal of Inflammation, vol. 1, article 3, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Ashizawa, R. Okada, Y. Suzuki et al., “Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor,” Gastric Cancer, vol. 8, no. 2, pp. 124–131, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ikeguchi, T. Hatada, M. Yamamoto et al., “Serum interleukin-6 and -10 levels in patients with gastric cancer,” Gastric Cancer, vol. 12, no. 2, pp. 95–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. W. Wu, S. R. Wang, M. F. Chao, et al., “Serum interleukin-6 levels reflect disease status of gastric cancer,” The American Journal of Gastroenterology, vol. 91, pp. 1417–1422, 1996.
  10. M. M. D'Elios, G. Del Prete, and A. Amedei, “Targeting IL-23 in human diseases,” Expert Opinion on Therapeutic Targets, vol. 14, pp. 759–774, 2010. View at Publisher · View at Google Scholar
  11. J. J. Michiels and M. Gawaz, “Preface: platelets in inflammation and atherothrombosis,” Seminars in Thrombosis and Hemostasis, vol. 33, no. 2, pp. 119–122, 2007. View at Publisher · View at Google Scholar
  12. J. N. George, “Platelets,” The Lancet, vol. 355, no. 9214, pp. 1531–1539, 2000. View at Scopus
  13. G. F. Nash, L. F. Turner, M. F. Scully, et al., “Platelets and cancer,” The Lancet Oncology, vol. 3, no. 7, pp. 425–430, 2002. View at Publisher · View at Google Scholar
  14. T. Rosch, “The new TNM classification in gastroenterology (1997),” Endoscopy, vol. 30, no. 7, pp. 643–649, 1998. View at Scopus
  15. W. Yasui, N. Oue, P. A. Phyu, S. Matsumura, M. Shutoh, and H. Nakayama, “Molecular-pathological prognostic factors of gastric cancer: a review,” Gastric Cancer, vol. 8, no. 2, pp. 86–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Blair and R. Flaumenhaft, “Platelet α-granules: basic biology and clinical correlates,” Blood Reviews, vol. 23, no. 4, pp. 177–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Ernst, “Review article: the role of inflammation in the pathogenesis of gastric cancer,” Alimentary Pharmacology & Therapeutics, vol. 13, supplement 1, pp. 13–18, 1999. View at Publisher · View at Google Scholar
  18. C. C. Folman, M. Ooms, B. Kuenen, et al., “The role of thrombopoietin in post-operative thrombocytosis,” British Journal of Haematology, vol. 114, no. 1, pp. 126–133, 2001. View at Publisher · View at Google Scholar
  19. P. Heras, A. Hatzopoulos, and N. Kritikos, “Platelet count and tumor progression in gastric cancer patients,” Scandinavian Journal of Gastroenterology, vol. 45, no. 7-8, pp. 1005–1006, 2010. View at Publisher · View at Google Scholar
  20. Y. Park, N. Schoene, and W. Harris, “Mean platelet volume as an indicator of platelet activation: methodological issues,” Platelets, vol. 13, no. 5-6, pp. 301–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Osada, M. Rusak, Z. Kamocki, M. I. Dabrowska, and B. Kedra, “Platelet activation in patients with advanced gastric cancer,” Neoplasma, vol. 57, no. 2, pp. 145–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. O. A. W. Haabeth, B. Bogen, and A. Corthay, “A model for cancer-suppressive inflammation,” OncoImmunology, vol. 1, no. 7, pp. 1146–1155, 2012. View at Publisher · View at Google Scholar
  23. C. S. Wang and C. F. Sun, “C-reactive protein and malignancy: clinico-pathological association and therapeutic implication,” Chang Gung Medical Journal, vol. 32, no. 5, pp. 471–482, 2009. View at Scopus
  24. Y. Kitadai, “Angiogenesis and lymphangiogenesis of gastric cancer,” Journal of Oncology, vol. 2010, 8 pages, 2010. View at Publisher · View at Google Scholar
  25. Y. Yin, X. Si, Y. Gao, et al., “The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma,” Oncology Reports, vol. 29, pp. 34–38, 2013.